We and others have made the important observation that the incidence of COPD is higher among the HIV infected population compared to the non-HIV infected population. In particular, HIV-infected smokers appear to be susceptible to an emphysema phenotype characterized physiologically by diffusion impairment. Preliminary data suggests that there are altered protein expression patterns in extracellular vesicles (EV) among HIV-infected smokers with and without emphysema. These patterns implicate a number of biologic pathways that may be dysregulated in HIV-associated emphysema, including the oxidative stress response, anti-protease mechanisms and surfactant homeostasis. Preliminary data also demonstrates that deregulation of microRNAs (miRNAs) may be a key driver of biological pathways implicated in the pathogenesis of emphysema, including oxidative stress, TGF beta, Map Kinase and Wnt pathways. In this investigation we will build on these observations and propose to examine the relevance of EV based biomarkers by developing a functional miRNA signature for HIV associated emphysema. We will do this by the systematic examination and integration of both proteomic and miRNA patterns within EVs. To achieve this objective we will pursue the following specific aims:
Specific Aim 1 : To test the hypothesis that alterations in lung EV protein expression profiles associated with HIV-induced emphysema can be distinguished from those pathways associated with emphysema in the HIV- uninfected population.
Specific Aim 2 : To investigate if lung EV miRNA expression drives distinct biological networks identified through deregulated proteins contributing to the pathogenesis of HIV associated emphysema.
Specific Aim 3 : To test the hypothesis that circulating EV based biomarkers may be associated with increased risk of lung damage occurring in HIV-infected smokers. Successful completion of this project will inform our knowledge of HIV-related lung disease and may also provide important insight into emphysema pathobiology.

Public Health Relevance

HIV-infected individuals are at increased risk of developing chronic obstructive pulmonary disease (COPD). As this population ages, chronic diseases such as COPD will likely become more and more prevalent among the HIV-infected population. This study seeks to identify important cellular processes that may be responsible for this increased risk. Successful completion of this study could eventually contribute to the development of new therapies to target COPD in both the HIV-infected and general population.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
1R01DA040395-01
Application #
8987353
Study Section
Special Emphasis Panel (ZDA1-JXR-G (13))
Program Officer
Purohit, Vishnudutt
Project Start
2015-08-01
Project End
2020-07-31
Budget Start
2015-08-01
Budget End
2016-07-31
Support Year
1
Fiscal Year
2015
Total Cost
$513,148
Indirect Cost
$163,148
Name
Ohio State University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
832127323
City
Columbus
State
OH
Country
United States
Zip Code
43210
Nana-Sinkam, Serge P; Acunzo, Mario; Croce, Carlo M et al. (2017) Extracellular Vesicle Biology in the Pathogenesis of Lung Disease. Am J Respir Crit Care Med 196:1510-1518
Barger, Jennifer F; Rahman, Mohammad A; Jackson, Devine et al. (2016) Extracellular miRNAs as biomarkers in cancer. Food Chem Toxicol 98:66-72